Brexpiprazole Appears Safe, Effective in Schizophrenia During Severe Psychotic Episodes


At 6 weeks of treatment, severely ill patients treated with adjunctive brexpiprazole had a greater reduction in PANSS total scores and CGI-S scores compared with those receiving placebo.